SRPK1 can act as a tumour suppressor by forming a complex with active AKT1 and the PHLPP1 phosphatase (alongside chaperones), which together inactivate AKT by dephosphorylating key regulatory sites. The gene discussed is SRPK1; the disease is neoplasm.